Why the study?
The effect of HDL on immune modulation is increasingly recognized to depend not only on HDL concentration but also, and perhaps even more so, on HDL function.
Key points are not available for this paper at this time.
Design
Review
HDL function may outweigh concentration for immunomodulation in CVD; leaves open whether function-targeted therapies improve outcomes.
High-density lipoprotein (HDL) plays an important role in lipid metabolism and especially contributes to the reverse cholesterol transport pathway. Over recent years it has become clear that the effect of HDL on immune-modulation is not only dependent on HDL concentration but also and perhaps even more so on HDL function. This review will provide a concise general introduction to HDL followed by an overview of post-translational modifications of HDL and a detailed overview of the role of HDL in inflammatory diseases. The clinical potential of HDL and its main apolipoprotein constituent, apoA-I, is also addressed in this context. Finally, some conclusions and remarks that are important for future HDL-based research and further development of HDL-focused therapies are discussed.
No takes yet. Share an insight, caveat, or question.
Nazir et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: